Company / Interest Expense
SOLENO THERAPEUTICS INC Interest Expense History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$5.5M
FY2025
5-year range
$231.0K / $5.5M
FY2024-FY2025
Trend
+2270.6%
vs FY2024
Sector context
#33 of 42
Health Care
What the data says
SOLENO THERAPEUTICS INC's interest expense of $5M is lower than 79% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$5M in FY2025.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 42This company $5.5M Sector average $305.3M
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2025, interest expense increased 2270.6% year-over-year.
- Ranks #33 out of 42 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.5M | +2270.6% |
| FY2024 | $231.0K | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026